3M Company

Latest reported revenue

$24.95BFY2025, December 31, 2025 · SEC XBRL

Reported cost proxy

$14.99BFY2025 · SEC XBRL

TRI facility leads

392024 U.S. match, unresolved

PFAS-listed forms reported

142024 U.S. TRI matched records; historical reporting

Top TRI facility

Decatur, ALEthylene glycol, top-reported chemical

3M's FY2025 Form 10-K identifies three continuing segments: Safety and Industrial, Transportation and Electronics, and Consumer. The former Health Care business was separated as Solventum in April 2024. [7]

01 · MATERIALS IN

Fluorochemicals, adhesives & specialty polymers

Not publicly disclosed at parent level in this source set beyond product-family description. Directional family: fluorochemical intermediates, acrylic and silicone adhesives, abrasive minerals, and specialty film resins.

02 · MAKE

Multi-site chemical & converting manufacturing

Chemical synthesis (including historical PFAS chemistry at Decatur, AL and Cottage Grove, MN) feeding downstream coating, laminating, and converting operations across a large U.S. and global plant network.

03 · PRODUCTS OUT

3 continuing business groups

Safety & Industrial, Transportation & Electronics, and Consumer, following the April 2024 spin-off of the Health Care business as Solventum. See the PFAS section for the manufacturing-exit and residual-treatment boundary.

04 · WASTE OUT

Listed-chemical & PFAS streams

59.8M lb managed in 2024 TRI records across 39 matched facility leads, including 14 separate PFAS-listed chemical forms.

What is public now

Ticker / CIK NYSE: MMM · SEC CIK 0000066740

FY2025 revenue & cost proxy $24.95B revenue, $14.99B reported cost proxy, period ended December 31, 2025 (SEC XBRL)

Business model Diversified industrial and consumer materials across three continuing business groups: Safety & Industrial, Transportation & Electronics, and Consumer, post-2024 Solventum spin-off

Public plant signal 39 U.S. facilities matched to a 3M parent name in the 2024 TRI dataset; the Decatur, AL chemical operations site is the top-volume named lead and a historically significant PFAS-manufacturing location

Evidence boundary
The reviewed sources do not identify a currently operating product platform using PFAS or an accepted fluorine-free substitute for a specific application. A named site and product are needed to evaluate a substitution case.

What the public record tells us

PFAS signal: 3M announced in December 2022 that it would exit PFAS manufacturing by the end of 2025. Its current stewardship page reports that the manufacturing exit was completed at the end of 2025, while remediation, asset disposition, and customer transitions remain active. Separately, 3M's FY2025 Form 10-K states total payments of $10.5 billion to $12.5 billion under the court-approved Public Water Systems Settlement, with payments from 2024 through 2036. Matched 2024 TRI records show 14 distinct PFAS-listed chemical forms; this is historical reporting, not a measure of current PFAS production.

Portfolio-simplification signal: 3M completed the spin-off of its Health Care business as an independent public company, Solventum, in April 2024, narrowing 3M itself to three continuing business groups. 3M’s FY2025 Form 10-K reports three continuing segments: Safety and Industrial, Transportation and Electronics, and Consumer.

Waste signal, with a caveat: Matched 2024 TRI records show 59.8M lb of listed chemicals managed nationally, led by ethylene glycol at the Decatur, AL site. Recycling is the largest single management category, but the PFAS-form count is the more consequential fact for a transition conversation than the aggregate weight.

Regulatory and certification signals

Regulatory watchlist EPA PFAS National Primary Drinking Water Regulation, TSCA PFAS reporting rule, state-level PFAS manufacturing and product bans, TRI listed-chemical and PFAS-form reporting

Certification & reporting families Company sustainability/ESG reporting, ISO 14001 site-level environmental management

How to use this view Full detail sits in the Regulatory section: connect each requirement to a named site before treating it as applicable

Innovation and recovery signals

Material innovation 3M reports that its PFAS manufacturing exit was completed at the end of 2025. The reviewed sources do not establish current application-level use or an accepted substitute.

Recovery pathways Closed-loop metal and polymer scrap, paint-sludge recovery, and composite recycling across Safety & Industrial and Transportation & Electronics product lines

Research scope
The reviewed sources do not map the matched TRI facilities to a current 3M product platform, active PFAS use or a specific substitution opportunity.

3M invented and commercialized PFOS and related fluorochemistry in the mid-20th century and has been at the center of PFAS regulatory, legal, and public-health attention for over two decades.

The 2025 PFAS manufacturing exit

3M announced its PFAS manufacturing-exit commitment in December 2022. Its current stewardship page reports that manufacturing ended by the close of 2025. Residual PFAS treatment, remediation, asset disposition and customer/product transitions continue. The manufacturing exit does not mean every PFAS-containing third-party product has left its portfolio. [8] [3]

The 2023 public water systems settlement

3M's FY2025 Form 10-K states that it will pay $10.5 billion to $12.5 billion in total under the court-approved Public Water Systems Settlement, with payments from 2024 through 2036. Open the FY2025 Form 10-K. This payment range is the filing's stated total for the settlement.

Named legacy manufacturing sites

3M’s Decatur, Alabama and Cottage Grove, Minnesota facilities are publicly documented as historically significant PFAS/PFOS manufacturing locations and remain subject to ongoing remediation and regulatory attention. The Decatur, AL site is also this brief’s top-matched 2024 TRI facility by managed weight (ethylene glycol), a genuine overlap between the legacy PFAS story and the current TRI evidence base worth naming directly rather than treating as coincidental.

PFAS reporting context

3M reports that it completed PFAS manufacturing at the end of 2025. The company also says that certain PFAS-containing products manufactured by third parties and used in some applications in its product portfolios will continue beyond 2025. The manufacturing exit is not evidence that every PFAS-containing product has left the portfolio. [3]

3M does not publicly itemize feedstock volumes by business group or site in this source set. The table below maps directional material families to known product-family and TRI disclosure, with PFAS-related chemistry called out separately given its regulatory and reputational weight.

Financial scale context

$24.95B FY2025 revenue and a $14.99B reported cost proxy (period ended December 31, 2025, SEC XBRL) provide scale context for 3M’s total raw-material purchasing post-Solventum spin-off. Neither figure is broken out by business group, site, or material family in this source set.

Material transition focus

3M reports that it completed its PFAS manufacturing exit at the end of 2025. The reviewed sources do not identify a current product application requiring PFAS or establish an accepted substitute for a named product platform. [3]

Publicly described product families across 3M’s three continuing business groups, post-2024 Solventum spin-off of the former Health Care segment.

Industrial adhesives & tapes

Acrylic and silicone-based bonding, mounting, and masking products.

Safety & Industrial

Personal protective equipment

Respirators, safety glasses, and industrial PPE.

Safety & Industrial

Abrasives & automotive aftermarket

Sanding, polishing, and vehicle-care products.

Safety & Industrial, Transportation & Electronics

Electronic & display films

Optical films, electronic-grade adhesives, and connectivity components.

Transportation & Electronics

Consumer tapes, sponges & home products

Scotch, Post-it, and household product lines.

Consumer

Former specialty-fluorochemical manufacturing

3M reports completing its PFAS manufacturing exit at the end of 2025. Remediation, asset disposition and customer transitions are separate ongoing activities. This disclosure does not establish current product availability. [3]

Historical manufacturing; current product availability not established

Product and application signal

Segment and product-family descriptions are public. Plant-level output volume by product line and customer-specific specification are not publicly disclosed. Treat any specific tonnage or grade claim as directional unless sourced to a named 3M filing or technical data sheet.

2024 TRI data gives a facility-level, U.S.-only view of 3M’s listed-chemical reporting, including 14 separate PFAS-listed chemical forms. This historical matched-record count does not establish current PFAS production.

Top named U.S. TRI facility lead (parent-name match, unresolved)

This is a candidate facility lead from parent-name matching against 2024 U.S. TRI records, excluded from any owned/operated plant count until ownership and operating control are verified. Decatur, AL is independently, publicly documented as a historically significant PFAS/PFOA-related manufacturing site, a genuine overlap with this brief’s PFAS signal, not a coincidence of matching.

National TRI footprint (2024, aggregate across 39 matched facilities)

Facilities matched to 3M parent name 39

Total listed chemicals reported (aggregate) 59,790,838 lb

Recycled on- or off-site (aggregate) 33,705,345 lb

Treated (aggregate) 23,687,394 lb

Energy recovery (aggregate) 265,735 lb

On-site release (aggregate) 1,731,990 lb

Off-site transfer (aggregate) 296,209 lb

PFAS-listed forms reported 14 · U.S. TRI matched records, 2024

Recycling is the dominant management category by weight, but the PFAS-form count, not the aggregate tonnage, is the fact that should anchor any transition conversation with 3M. Components are shown as reported and may not sum exactly to the published total due to EPA rounding or categorization conventions.

PFAS-form signal

The matched 2024 filings predate 3M's reported end-2025 PFAS manufacturing exit. A historical form count does not establish present production or completion of remediation. [3]

Process-chemistry signal

Ethylene glycol as the top-reported chemical at a large multi-product chemical-operations site is consistent with its broad use as a solvent, coolant, and polyester-precursor intermediate rather than being PFAS-specific; the PFAS signal sits in the separate form-count metric above.

Scope limitation

TRI parent-name matching only reaches U.S. facilities filed under a 3M corporate name and only covers the specific listed chemicals tracked in this source set. It is not a complete emissions or waste inventory for 3M’s full global footprint, and it says nothing about international PFAS remediation obligations 3M has separately disclosed.

These are Material Transition research questions, not 3M projects. The reviewed sources report that 3M completed its PFAS manufacturing exit at the end of 2025; historical TRI records do not establish current use in a specific product.

Fluorine-free chemistry qualification, named product platform

A product-level review could test whether any current 3M application still requires fluorinated chemistry and what alternatives meet its specification. The sources reviewed here do not identify a currently operating 3M product platform using PFAS or an accepted substitute.

• Product and application evidence, if a current fluorinated use is identified
• Required performance and regulatory specifications
• Candidate alternatives and qualification evidence, if a substitution need exists

Post-spin-off segment realignment

The 2024 Solventum spin-off changed 3M’s reporting structure; a review of which material-transition opportunities moved to Solventum versus remaining with 3M is a genuine, current-state clarification opportunity.

• Confirmed post-spin-off segment and product-line mapping
• Named 3M (not Solventum) plant and product
• Current segment-reporting alignment

Recycled polymer & metal content, industrial product lines

Safety & Industrial and Transportation & Electronics abrasives, tapes, and films are a large-volume category where recycled-content substitution is a concrete, non-PFAS-related opportunity.

• Named product line and current material specification
• Recycled-content supplier qualification
• Mechanical and adhesion-performance equivalence data

Decatur, AL site-specific remediation-adjacent partnership

Historical public records identify Decatur as a significant PFAS-manufacturing location, while matched 2024 TRI records are a separate historical reporting signal. Neither establishes a current non-PFAS residual stream, available material, recoverability, or a current remediation boundary at the site; those would require current site-specific evidence.

• Named non-PFAS residual stream at Decatur
• Recovery or recycling processor relationship
• Clear separation from ongoing PFAS remediation workstreams

Priority opportunity

Qualification boundary: The reviewed sources do not establish a current 3M product platform using PFAS or a specific application with an accepted fluorine-free substitute. The completed manufacturing exit, residual treatment, remediation and customer/product transitions are distinct activities and should not be conflated.

This section summarizes PFAS-specific federal and state frameworks. Their inclusion does not establish the cause of a company decision.

Regulatory applicability has not been adjudicated per site here. This is a watchlist, not a legal conclusion.

Certification & reporting families in play

Certificate scope and current status are not verified here. Certification-family relevance does not prove an active, in-scope certificate at any named site.

Innovation & capacity signals

PFAS exit commitment Publicly dated commitment to exit all PFAS manufacturing by end of 2025, announced December 2022

2023 Public Water Systems Settlement FY2025 Form 10-K: $10.5B–$12.5B total payments, scheduled from 2024 through 2036

Solventum spin-off April 2024 spin-off of the former Health Care business as an independent public company

This brief separates the disclosed record from the evidence still needed. Bring the relevant specification, facility or product-family evidence into the review.